Ad
related to: cholinergic agonist effects on the body and liver enzymes are found
Search results
Results from the WOW.Com Content Network
Cholinergic blocking drugs are a group of drugs that block the action of acetylcholine (ACh), a neurotransmitter, in synapses of the cholinergic nervous system. [1] They block acetylcholine from binding to cholinergic receptors, namely the nicotinic and muscarinic receptors.
The cholinergic anti-inflammatory pathway provides a braking effect on the innate immune response which protects the body against the damage that can occur if a localized inflammatory response spreads beyond the local tissues, which results in toxicity or damage to the kidney, liver, lungs, and other organs. [5]
Cholinergic agents are compounds which mimic the action of acetylcholine and/or butyrylcholine. [1] In general, the word " choline " describes the various quaternary ammonium salts containing the N , N , N -trimethylethanolammonium cation .
Acetylcholine is a choline molecule that has been acetylated at the oxygen atom. Because of the charged ammonium group, acetylcholine does not penetrate lipid membranes. . Because of this, when the molecule is introduced externally, it remains in the extracellular space and at present it is considered that the molecule does not pass through the blood–brain
Nicotinic receptors are the primary mediator of the effects of nicotine. In myasthenia gravis , the receptor at the neuromuscular junction is targeted by antibodies , leading to muscle weakness. Muscarinic acetylcholine receptors can be blocked by the drugs atropine and scopolamine .
A parasympathomimetic drug, sometimes called a cholinomimetic drug [1] or cholinergic receptor stimulating agent, [2] is a substance that stimulates the parasympathetic nervous system (PSNS). [ 3 ] [ 2 ] These chemicals are also called cholinergic drugs because acetylcholine (ACh) is the neurotransmitter used by the PSNS.
It is found at mainly neuromuscular junctions and in chemical synapses of the cholinergic type, where its activity serves to terminate cholinergic synaptic transmission. It belongs to the carboxylesterase family of enzymes. It is the primary target of inhibition by organophosphorus compounds such as nerve agents and pesticides.
Both M 2 and M 3 muscarinic receptors are expressed in the smooth muscles of the airway, with the majority of the receptors being the M 2 type. Activation of the M 2 receptors, which are coupled to G i, inhibits the β-adrenergic mediated relaxation of the airway smooth muscle.
Ad
related to: cholinergic agonist effects on the body and liver enzymes are found